AAAAAA
Results:
1-13
|
Results: 13
Authors:
Van Weyenbergh, J
Wietzerbin, J
Rouillard, D
Barral-Netto, M
Liblau, R
Citation: J. Van Weyenbergh et al., Treatment of multiple sclerosis patients with interferon-beta primes monocyte-derived macrophages for apoptotic cell death, J LEUK BIOL, 70(5), 2001, pp. 745-748
Authors:
Liblau, R
Citation: R. Liblau, Contribution of laboratory tests to the diagnosis of multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 963-967
Authors:
Willison, HJ
Ang, W
Gilhus, NE
Graus, F
Liblau, R
Vedeler, C
Vincent, A
Citation: Hj. Willison et al., EFNS Task Force Report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres, EUR J NEUR, 7(6), 2000, pp. 625-628
Authors:
Chabas, D
Liblau, R
Citation: D. Chabas et R. Liblau, What is the role of autoimmunity in multiple sclerosis?, PATH BIOL, 48(1), 2000, pp. 25-46
Authors:
Reboul, J
Mertens, C
Levillayer, F
Eichenbaum-Voline, S
Vilkoren, T
Cournu, I
Babron, MC
Lyon-Caen, O
Clerget-Darpoux, F
Edan, G
Clanet, M
Brahic, M
Bureau, JF
Fontaine, B
Liblau, R
Citation: J. Reboul et al., Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach, J NEUROIMM, 102(1), 2000, pp. 107-112
Authors:
Bercovici, N
Heurtier, A
Vizler, C
Pardigon, N
Cambouris, C
Desreumaux, P
Liblau, R
Citation: N. Bercovici et al., Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage, J IMMUNOL, 165(1), 2000, pp. 202-210
Authors:
Pardigon, N
Cambouris, C
Bercovici, N
Lemaitre, F
Liblau, R
Kourilsky, P
Citation: N. Pardigon et al., Delayed and separate costimulation in vitro supports the evidence of a transient "excited" state of CD8(+) T cells during activation, J IMMUNOL, 164(9), 2000, pp. 4493-4499
Authors:
Benyahia, B
Liblau, R
Merle-Beral, H
Tourani, JM
Dalmau, J
Delattre, JY
Citation: B. Benyahia et al., Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies, ANN NEUROL, 45(2), 1999, pp. 162-167
Authors:
Tourbah, A
Stievenart, JL
Gout, O
Fontaine, B
Liblau, R
Lubetzki, C
Cabanis, EA
Lyon-Caen, O
Citation: A. Tourbah et al., Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis, NEUROLOGY, 53(5), 1999, pp. 1091-1097
Authors:
Tourbah, A
Gout, O
Liblau, R
Lyon-Caen, O
Bougniot, C
Iba-Zizen, MT
Cabanis, EA
Citation: A. Tourbah et al., Encephalitis after hepatitis B vaccination - Recurrent disseminated encephalitis or MS?, NEUROLOGY, 53(2), 1999, pp. 396-401
Authors:
Theodorou, I
Liblau, R
Uchuya, M
Delattre, JY
Citation: I. Theodorou et al., Lack of association between human leukocyte antigens and anti-Hu syndrome in patients with small-cell lung cancer - Reply from the authors, NEUROLOGY, 52(2), 1999, pp. 431-431
Authors:
Scotet, E
Peyrat, MA
Saulquin, X
Retiere, C
Couedel, C
Davodeau, F
Dulphy, N
Toubert, A
Bignon, JD
Lim, A
Vie, H
Hallet, MM
Liblau, R
Weber, M
Berthelot, JM
Houssaint, E
Bonneville, M
Citation: E. Scotet et al., Frequent enrichment for CD8 T cells reactive against common herpes virusesin chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes, EUR J IMMUN, 29(3), 1999, pp. 973-985
Authors:
Liblau, R
Benyahia, B
Delattre, JY
Citation: R. Liblau et al., The pathophysiology of paraneoplastic neurological syndromes, ANN MED IN, 149(8), 1998, pp. 512-520
Risultati:
1-13
|